MAHA Is Sick: RFK’s FDA Is Drifting the Wrong Way
Conservatives expected less bureaucracy. Instead they’re seeing slower approvals, tougher hurdles, and a regulator who doesn’t trust patients to weigh risk.
Comment
Show comments
Hide Comments
